Bristol Myers Squibb (BMY)

Operating Expenses

$20.67B

TTM · Period ending: · USD

BMY logo

BMY Operating Expenses

Latest reported$20.67B
BMY TTM Operating Expenses ($6.09B → $20.67B)
High-resolution chart · PNG

BMY operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
7,780,000,000
8,471,000,000
8,642,000,000
9,151,000,000
8,979,000,000
8,808,000,000
9,081,000,000
8,923,000,000
9,214,000,000
9,015,000,000
8,932,000,000
8,872,000,000
8,715,000,000
8,579,000,000
8,390,000,000
8,103,000,000
7,926,000,000
7,790,000,000
7,665,000,000
7,598,000,000
7,402,000,000
7,228,000,000
6,963,000,000
6,660,000,000
6,428,000,000
6,204,000,000
5,967,000,000
6,422,000,000
6,394,000,000
6,317,000,000
6,288,000,000
6,283,000,000
6,478,000,000
6,553,000,000
6,634,000,000
6,120,000,000
5,898,000,000
5,739,000,000
5,709,000,000
5,631,000,000
5,552,000,000
5,419,000,000
5,281,000,000
11,819,000,000
10,573,000,000
9,331,000,000
8,106,000,000
6,788,000,000
6,788,000,000
6,788,000,000
6,788,000,000
6,091,000,000
6,091,000,000
6,091,000,000
6,091,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.